Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
about
Clinical Implications of Glucose Variability: Chronic Complications of DiabetesThe structure of substrate-free 1,5-anhydro-D-fructose reductase fromSinorhizobium meliloti1021 reveals an open enzyme conformationGlycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1cThe roles of glycated albumin as intermediate glycation index and pathogenic protein.Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy.Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.Serum bilirubin levels are positively associated with glycemic variability in women with type 2 diabetes.1,5-Anhydroglucitol in diabetes mellitus.The impact of glycemic variability on diabetic peripheral neuropathy.How can we easily measure glycemic variability in diabetes mellitus?HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.Improved Insulin Secretion by Autologous Islet Transplantation, Compared to Oral Antidiabetic Agents, After Distal Pancreatectomy.
P2860
Q26801671-8848D041-4369-42E9-86A6-8D8FFFD5B0AEQ27679332-7A9D0C43-3406-4F12-A529-52499951C1FDQ35101926-3421BB66-F2DF-4717-B0D4-B10F87C30750Q35911117-8475368F-20B0-4E02-8D89-9017EE62C9C7Q36900001-8658B734-C9B7-4AF9-8E7E-861919246CB6Q37043631-4D31E4BB-C373-4FC6-A6B1-FD266AA04167Q37292095-CDC54F12-2F46-4F73-9CC0-80D328909C06Q37385520-314A8E65-4450-45F2-960A-2F9D608C0F2BQ38030840-26412B33-A9A6-49A4-B0A3-91CE4A3CD364Q38887664-DE7536AC-3F79-4D43-83FF-B3651EB7F1BBQ39996070-1CFF3C81-C70D-457C-8B69-05123700D3D2Q40364101-E19B0931-CD87-45EE-9890-A06C3FA2DC00Q51052616-FAD4E10F-E491-42DD-8AE3-EF1CE728B572Q51272348-CA7A9602-E89D-4776-8D50-724315A1ED8EQ53272501-0E50F93A-4741-48E0-8F17-D4A7129A4045
P2860
Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@en
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@nl
type
label
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@en
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@nl
prefLabel
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@en
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@nl
P2093
P2860
P1433
P1476
Evaluation of 1,5-anhydrogluci ...... with type 2 diabetes mellitus.
@en
P2093
Hak Chul Jang
Hye Seung Jung
Kyong Soo Park
Min Joo Kim
Seong Yeon Kim
Sun Wook Cho
Yul Hwang-Bo
P2860
P2888
P304
P356
10.1007/S00592-011-0302-0
P577
2011-06-18T00:00:00Z